We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers.
- Authors
Ramirez-Lorca, R; Boada, M; Saez, M E; Hernandez, I; Mauleon, A; Rosende-Roca, M; Martinez-Lage, P; Gutierrez, M; Real, L M; Lopez-Arrieta, J; Gayan, J; Antunez, C; Gonzalez-Perez, A; Tarraga, L; Ruiz, A
- Abstract
The genetic basis of Alzheimer's disease (AD) is being analyzed in multiple whole genome association studies (WGAS). The GAB2 gene has been proposed as a modifying factor of APOE epsilon 4 allele in a recent case-control WGAS conducted in the US. Given the potential application of these novel results in AD diagnostics, we decided to make an independent replication to examine the GAB2 gene effect in our series.
- Publication
The journal of nutrition, health & aging, 2009, Vol 13, Issue 3, p214
- ISSN
1279-7707
- Publication type
Journal Article
- DOI
10.1007/s12603-009-0061-6